National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 3)(No. PB 28 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L00400

 
PB 28 of 2014
National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 3)
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated                                          9 April 2014
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 3).
            (2)        This Instrument may also be cited as PB 28 of 2014.
2          Commencement
            This Instrument commences on 1 May 2014.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 25]
(a)   omit from the column headed “Determined Price”:             16.05     substitute:             11.97
(b)   omit from the column headed “Claimed Price”:                  17.15     substitute:             12.79
[2] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 90]
omit from the column headed “Claimed Price”:          59.39    substitute:             44.29
[3] Schedule 1, entry for Aciclovir in the form Tablet 800 mg
(a)   omit from the column headed “Determined Price”:             69.90     substitute:             52.11
(b)   omit from the column headed “Claimed Price”:                  70.69     substitute:             52.70
[4] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
(a)   omit from the column headed “Determined Price”:             2.44        substitute:             1.68
(b)   omit from the column headed “Claimed Price”:                  5.47        substitute:             3.77
[5] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
(a)   omit from the column headed “Determined Price”:             4.28        substitute:             2.94
(b)   omit from the column headed “Claimed Price”:                  8.72        substitute:             5.99
[6] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
(a)   omit from the column headed “Determined Price”:             0.85        substitute:             0.72
(b)   omit from the column headed “Claimed Price”:                  3.44        substitute:             2.91
[7] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
(a)   omit from the column headed “Determined Price”:             1.69        substitute:             1.43
(b)   omit from the column headed “Claimed Price”:                  4.28        substitute:             3.62
[8] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             0.76        substitute:             0.64
(b)   omit from the column headed “Claimed Price”:                  3.35        substitute:             2.82
[9] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             1.09        substitute:             0.92
(b)   omit from the column headed “Claimed Price”:                  3.68        substitute:             3.11
 
[10]         Schedule 1, entry for Amoxycillin in the form Tablet 1 g (as trihydrate)
(a)   omit from the column headed “Determined Price”:             1.74        substitute:             1.47
(b)   omit from the column headed “Claimed Price”:                  2.20        substitute:             1.86
[11]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin
(as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
(a)   omit from the column headed “Determined Price”:             1.47        substitute:             1.26
(b)   omit from the column headed “Claimed Price”:                  3.90        substitute:             3.34
[12]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin
(as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
(a)   omit from the column headed “Determined Price”:             2.10        substitute:             1.80
(b)   omit from the column headed “Claimed Price”:                  5.51        substitute:             4.72
[13]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with
125 mg clavulanic acid (as potassium clavulanate)
(a)   omit from the column headed “Determined Price”:             2.40        substitute:             2.06
(b)   omit from the column headed “Claimed Price”:                  5.75        substitute:             4.94
[14]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with
125 mg clavulanic acid (as potassium clavulanate)
(a)   omit from the column headed “Determined Price”:             3.41        substitute:             2.93
(b)   omit from the column headed “Claimed Price”:                  7.63        substitute:             6.56
[15]         Schedule 1, entry for Atenolol
(a)   omit from the column headed “Determined Price”:             1.55        substitute:             1.32
(b)   omit from the column headed “Claimed Price”:                  3.86        substitute:             3.29
[16]         Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             2.46        substitute:             2.17
(b)   omit from the column headed “Claimed Price”:                  6.91        substitute:             6.10
[17]         Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
(a)   omit from the column headed “Determined Price”:             2.64        substitute:             2.33
(b)   omit from the column headed “Claimed Price”:                  7.27        substitute:             6.42
 
[18]         Schedule 1, entry for Cefaclor in the form Tablet (sustained release) 375 mg (as monohydrate)
(a)   omit from the column headed “Determined Price”:             3.51        substitute:             3.10
(b)   omit from the column headed “Claimed Price”:                  8.92        substitute:             7.88
[19]         Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)
(a)   omit from the column headed “Determined Price”:             1.04        substitute:             0.91
(b)   omit from the column headed “Claimed Price”:                  4.41        substitute:             3.86
[20]         Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)
(a)   omit from the column headed “Determined Price”:             1.86        substitute:             1.64
(b)   omit from the column headed “Claimed Price”:                  6.73        substitute:             5.93
[21]         Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             1.24        substitute:             1.09
(b)   omit from the column headed “Claimed Price”:                  4.95        substitute:             4.35
[22]         Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             1.84        substitute:             1.62
(b)   omit from the column headed “Claimed Price”:                  6.66        substitute:             5.86
[23]         Schedule 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             6.54        substitute:             5.12
(b)   omit from the column headed “Claimed Price”:                  7.02        substitute:             5.50
[24]         Schedule 1, entry for Ciprofloxacin in the form Tablet 500 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             12.79     substitute:             10.01
(b)   omit from the column headed “Claimed Price”:                  13.28     substitute:             10.39
[25]         Schedule 1, entry for Ciprofloxacin in the form Tablet 750 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             19.28     substitute:             15.09
(b)   omit from the column headed “Claimed Price”:                  19.76     substitute:             15.47
[26]         Schedule 1, entry for Citalopram
(a)   omit from the column headed “Determined Price”:             3.56        substitute:             2.43
(b)   omit from the column headed “Claimed Price”:                  5.81        substitute:             3.97
 
[27]         Schedule 1, entry for Clomipramine
(a)   omit from the column headed “Determined Price”:             7.01        substitute:             6.25
(b)   omit from the column headed “Claimed Price”:                  9.49        substitute:             8.46
[28]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 20]
(a)   omit from the column headed “Determined Price”:             23.79     substitute:             20.22
(b)   omit from the column headed “Claimed Price”:                  26.11     substitute:             22.19
[29]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 50]
omit from the column headed “Claimed Price”:          60.59    substitute:             51.50
[30]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg
(a)   omit from the column headed “Determined Price”:             92.66     substitute:             78.74
(b)   omit from the column headed “Claimed Price”:                  93.60     substitute:             79.54
[31]         Schedule 1, entry for Diazepam in the form Tablet 2 mg
(a)   omit from the column headed “Determined Price”:             1.05        substitute:             0.94
(b)   omit from the column headed “Claimed Price”:                  1.71        substitute:             1.53
[32]         Schedule 1, entry for Diazepam in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             1.15        substitute:             1.03
(b)   omit from the column headed “Claimed Price”:                  1.84        substitute:             1.65
[33]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
(a)   omit from the column headed “Determined Price”:             2.03        substitute:             1.76
(b)   omit from the column headed “Claimed Price”:                  2.78        substitute:             2.41
[34]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
(a)   omit from the column headed “Determined Price”:             2.83        substitute:             2.45
(b)   omit from the column headed “Claimed Price”:                  4.33        substitute:             3.75
[35]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity: 7]
(a)   omit from the column headed “Determined Price”:             1.23        substitute:             1.03
(b)   omit from the column headed “Claimed Price”:                  3.50        substitute:             2.93
 
[36]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity: 21]
omit from the column headed “Claimed Price”:          9.00      substitute:             7.54
[37]         Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
(a)   omit from the column headed “Determined Price”:             2.19        substitute:             1.83
(b)   omit from the column headed “Claimed Price”:                  6.00        substitute:             5.01
[38]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg
(a)   omit from the column headed “Determined Price”:             2.92        substitute:             2.60
(b)   omit from the column headed “Claimed Price”:                  6.69        substitute:             5.96
[39]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
(a)   omit from the column headed “Determined Price”:             4.80        substitute:             4.28
(b)   omit from the column headed “Claimed Price”:                  8.56        substitute:             7.63
[40]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
(a)   omit from the column headed “Determined Price”:             6.12        substitute:             5.45
(b)   omit from the column headed “Claimed Price”:                  9.89        substitute:             8.81
[41]         Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
(a)   omit from the column headed “Determined Price”:             7.47        substitute:             4.72
(b)   omit from the column headed “Claimed Price”:                  11.26     substitute:             7.12
[42]         Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
(a)   omit from the column headed “Determined Price”:             7.53        substitute:             4.76
(b)   omit from the column headed “Claimed Price”:                  13.08     substitute:             8.27
[43]         Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
(a)   omit from the column headed “Determined Price”:             4.19        substitute:             3.44
(b)   omit from the column headed “Claimed Price”:                  7.31        substitute:             6.00
[44]         Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
(a)   omit from the column headed “Determined Price”:             6.03        substitute:             4.95
(b)   omit from the column headed “Claimed Price”:                  9.14        substitute:             7.50
 
[45]         Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
(a)   omit from the column headed “Determined Price”:             10.91     substitute:             8.96
(b)   omit from the column headed “Claimed Price”:                  14.03     substitute:             11.52
[46]         Schedule 1, entry for Fluoxetine in the form Capsule 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             7.34        substitute:             5.81
(b)   omit from the column headed “Claimed Price”:                  9.68        substitute:             7.66
[47]         Schedule 1, entry for Fluoxetine in the form Tablet, dispersible, 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             7.34        substitute:             5.81
(b)   omit from the column headed “Claimed Price”:                  9.68        substitute:             7.66
[48]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg
(a)   omit from the column headed “Determined Price”:             7.59        substitute:             6.71
(b)   omit from the column headed “Claimed Price”:                  9.20        substitute:             8.13
[49]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg
(a)   omit from the column headed “Determined Price”:             11.50     substitute:             10.17
(b)   omit from the column headed “Claimed Price”:                  13.11     substitute:             11.59
[50]         Schedule 1, entry for Frusemide in the form Tablet 20 mg
(a)   omit from the column headed “Determined Price”:             0.84        substitute:             0.71
(b)   omit from the column headed “Claimed Price”:                  1.62        substitute:             1.37
[51]         Schedule 1, entry for Frusemide in the form Tablet 40 mg
(a)   omit from the column headed “Determined Price”:             1.53        substitute:             1.29
(b)   omit from the column headed “Claimed Price”:                  3.48        substitute:             2.93
[52]         Schedule 1, entry for Gemfibrozil in the form Tablet 600 mg
(a)   omit from the column headed “Determined Price”:             10.33     substitute:             9.21
(b)   omit from the column headed “Claimed Price”:                  11.64     substitute:             10.38
[53]         Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous)
in 1 mL single dose units, 30
(a)   omit from the column headed “Determined Price”:             9.84        substitute:             8.71
(b)   omit from the column headed “Claimed Price”:                  10.06     substitute:             8.91
 
[54]         Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous)
in 1 mL single dose units, 30
(a)   omit from the column headed “Determined Price”:             11.63     substitute:             10.29
(b)   omit from the column headed “Claimed Price”:                  11.85     substitute:             10.48
[55]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Imdur Durule]
(a)   omit from the column headed “Determined Price”:             3.98        substitute:             3.58
(b)   omit from the column headed “Claimed Price”:                  7.01        substitute:             6.31
[56]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Monodur 60 mg]
(a)   omit from the column headed “Determined Price”:             3.98        substitute:             3.58
(b)   omit from the column headed “Claimed Price”:                  6.20        substitute:             5.58
[57]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)
(a)   omit from the column headed “Determined Price”:             9.42        substitute:             8.47
(b)   omit from the column headed “Claimed Price”:                  12.45     substitute:             11.20
[58]         Schedule 1, entry for Lamotrigine in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             4.93        substitute:             4.23
(b)   omit from the column headed “Claimed Price”:                  6.11        substitute:             5.24
[59]         Schedule 1, entry for Lamotrigine in the form Tablet 25 mg
(a)   omit from the column headed “Determined Price”:             10.97     substitute:             9.42
(b)   omit from the column headed “Claimed Price”:                  12.16     substitute:             10.44
[60]         Schedule 1, entry for Lamotrigine in the form Tablet 50 mg
(a)   omit from the column headed “Determined Price”:             18.30     substitute:             15.71
(b)   omit from the column headed “Claimed Price”:                  19.66     substitute:             16.88
[61]         Schedule 1, entry for Lamotrigine in the form Tablet 100 mg
(a)   omit from the column headed “Determined Price”:             30.48     substitute:             26.17
(b)   omit from the column headed “Claimed Price”:                  31.72     substitute:             27.23
[62]         Schedule 1, entry for Lamotrigine in the form Tablet 200 mg
(a)   omit from the column headed “Determined Price”:             51.21     substitute:             43.97
(b)   omit from the column headed “Claimed Price”:                  52.44     substitute:             45.02
 
[63]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
(a)   omit from the column headed “Determined Price”:             3.55        substitute:             2.90
(b)   omit from the column headed “Claimed Price”:                  5.70        substitute:             4.66
[64]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
(a)   omit from the column headed “Determined Price”:             5.93        substitute:             4.84
(b)   omit from the column headed “Claimed Price”:                  8.08        substitute:             6.59
[65]         Schedule 1, entry for Lisinopril in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             3.49        substitute:             3.06
(b)   omit from the column headed “Claimed Price”:                  6.52        substitute:             5.72
[66]         Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Prinivril 10]
(a)   omit from the column headed “Determined Price”:             5.23        substitute:             4.58
(b)   omit from the column headed “Claimed Price”:                  8.27        substitute:             7.24
[67]         Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Zestril]
(c)   omit from the column headed “Determined Price”:             5.23        substitute:             4.58
(d)   omit from the column headed “Claimed Price”:                  8.26        substitute:             7.23
[68]         Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Prinivril 20]
(a)   omit from the column headed “Determined Price”:             6.59        substitute:             5.78
(b)   omit from the column headed “Claimed Price”:                  9.63        substitute:             8.45
[69]         Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Zestril]
(a)   omit from the column headed “Determined Price”:             6.59        substitute:             5.78
(b)   omit from the column headed “Claimed Price”:                  9.63        substitute:             8.45
[70]         Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg
(a)   omit from the column headed “Determined Price”:             6.82        substitute:             4.95
(b)   omit from the column headed “Claimed Price”:                  8.24        substitute:             5.98
[71]         Schedule 1, entry for Meloxicam in the form Capsule 15 mg
(a)   omit from the column headed “Determined Price”:             9.95        substitute:             7.22
(b)   omit from the column headed “Claimed Price”:                  11.37     substitute:             8.25
 
[72]         Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
(a)   omit from the column headed “Determined Price”:             6.82        substitute:             4.95
(b)   omit from the column headed “Claimed Price”:                  8.24        substitute:             5.98
[73]         Schedule 1, entry for Meloxicam in the form Tablet 15 mg
(a)   omit from the column headed “Determined Price”:             9.95        substitute:             7.22
(b)   omit from the column headed “Claimed Price”:                  11.37     substitute:             8.25
[74]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
(a)   omit from the column headed “Determined Price”:             3.60        substitute:             3.16
(b)   omit from the column headed “Claimed Price”:                  4.57        substitute:             4.01
[75]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]
(a)   omit from the column headed “Determined Price”:             3.60        substitute:             3.16
(b)   omit from the column headed “Claimed Price”:                  4.57        substitute:             4.01
[76]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Glucophage]
(a)   omit from the column headed “Determined Price”:             3.60        substitute:             3.16
(b)   omit from the column headed “Claimed Price”:                  4.19        substitute:             3.68
[77]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
(a)   omit from the column headed “Determined Price”:             6.29        substitute:             5.51
(b)   omit from the column headed “Claimed Price”:                  7.28        substitute:             6.38
[78]         Schedule 1, entry for Methylprednisolone
(a)   omit from the column headed “Determined Price”:             12.10     substitute:             13.91
(b)   omit from the column headed “Claimed Price”:                  12.87     substitute:             15.09
[79]         Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             10.29     substitute:             7.46
(b)   omit from the column headed “Claimed Price”:                  11.25     substitute:             8.16
[80]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
(a)   omit from the column headed “Determined Price”:             8.95        substitute:             6.49
(b)   omit from the column headed “Claimed Price”:                  11.77     substitute:             8.53
 
[81]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             13.72     substitute:             9.94
(b)   omit from the column headed “Claimed Price”:                  14.69     substitute:             10.64
[82]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
(a)   omit from the column headed “Determined Price”:             14.93     substitute:             10.82
(b)   omit from the column headed “Claimed Price”:                  17.76     substitute:             12.87
[83]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             20.68     substitute:             14.98
(b)   omit from the column headed “Claimed Price”:                  21.66     substitute:             15.69
[84]         Schedule 1, entry for Moclobemide in the form Tablet 150 mg
(a)   omit from the column headed “Determined Price”:             6.63        substitute:             5.77
(b)   omit from the column headed “Claimed Price”:                  7.02        substitute:             6.11
[85]         Schedule 1, entry for Moclobemide in the form Tablet 300 mg
(a)   omit from the column headed “Determined Price”:             12.77     substitute:             11.11
(b)   omit from the column headed “Claimed Price”:                  13.54     substitute:             11.78
[86]         Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g
(a)   omit from the column headed “Determined Price”:             5.09        substitute:             4.52
(b)   omit from the column headed “Claimed Price”:                  7.88        substitute:             7.00
[87]         Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL
(a)   omit from the column headed “Determined Price”:             8.02        substitute:             7.13
(b)   omit from the column headed “Claimed Price”:                  10.81     substitute:             9.61
[88]         Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g
(a)   omit from the column headed “Determined Price”:             5.09        substitute:             4.52
(b)   omit from the column headed “Claimed Price”:                  7.88        substitute:             7.00
[89]         Schedule 1, entry for Nifedipine in the form Tablet 10 mg
(a)   omit from the column headed “Determined Price”:             5.85        substitute:             5.20
(b)   omit from the column headed “Claimed Price”:                  6.61        substitute:             5.88
 
[90]         Schedule 1, entry for Nifedipine in the form Tablet 20 mg
(a)   omit from the column headed “Determined Price”:             7.20        substitute:             6.40
(b)   omit from the column headed “Claimed Price”:                  8.62        substitute:             7.66
[91]         Schedule 1, entry for Nifedipine in the form Tablet 30 mg (controlled release)
(a)   omit from the column headed “Determined Price”:             8.09        substitute:             7.19
(b)   omit from the column headed “Claimed Price”:                  9.74        substitute:             8.66
[92]         Schedule 1, entry for Nifedipine in the form Tablet 60 mg (controlled release)
(a)   omit from the column headed “Determined Price”:             10.16     substitute:             9.03
(b)   omit from the column headed “Claimed Price”:                  11.97     substitute:             10.64
[93]         Schedule 1, entry for Omeprazole
(a)   omit from the column headed “Determined Price”:             8.55        substitute:             6.78
(b)   omit from the column headed “Claimed Price”:                  11.66     substitute:             9.25
[94]         Schedule 1, entry for Paroxetine
(a)   omit from the column headed “Determined Price”:             6.31        substitute:             5.29
(b)   omit from the column headed “Claimed Price”:                  8.09        substitute:             6.78
[95]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
(a)   omit from the column headed “Determined Price”:             3.84        substitute:             2.81
(b)   omit from the column headed “Claimed Price”:                  5.98        substitute:             4.38
[96]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
(a)   omit from the column headed “Determined Price”:             6.10        substitute:             4.46
(b)   omit from the column headed “Claimed Price”:                  8.23        substitute:             6.02
[97]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
(a)   omit from the column headed “Determined Price”:             9.50        substitute:             6.94
(b)   omit from the column headed “Claimed Price”:                  11.77     substitute:             8.60
[98]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
(a)   omit from the column headed “Determined Price”:             14.60     substitute:             10.67
(b)   omit from the column headed “Claimed Price”:                  16.87     substitute:             12.33
 
[99]         Schedule 1, entry for Prochlorperazine
(a)   omit from the column headed “Determined Price”:             1.83        substitute:             1.47
(b)   omit from the column headed “Claimed Price”:                  4.62        substitute:             3.71
[100]       Schedule 1, entry for Quinapril in the form Tablet 5 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             3.66        substitute:             3.27
(b)   omit from the column headed “Claimed Price”:                  4.98        substitute:             4.45
[101]       Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             5.23        substitute:             4.68
(b)   omit from the column headed “Claimed Price”:                  6.55        substitute:             5.86
[102]       Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             6.47        substitute:             5.78
(b)   omit from the column headed “Claimed Price”:                  7.79        substitute:             6.96
[103]       Schedule 1, entry for Ranitidine in the form Tablet 150 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             6.46        substitute:             5.24
(b)   omit from the column headed “Claimed Price”:                  7.85        substitute:             6.37
[104]       Schedule 1, entry for Ranitidine in the form Tablet 300 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             6.46        substitute:             5.24
(b)   omit from the column headed “Claimed Price”:                  7.85        substitute:             6.37
[105]       Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
(a)   omit from the column headed “Determined Price”:             4.15        substitute:             3.72
(b)   omit from the column headed “Claimed Price”:                  4.62        substitute:             4.14
[106]       Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
(a)   omit from the column headed “Determined Price”:             4.38        substitute:             3.92
(b)   omit from the column headed “Claimed Price”:                  4.85        substitute:             4.34
[107]       Schedule 1, entry for Sertraline in the form Tablet 50 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             4.73        substitute:             3.15
(b)   omit from the column headed “Claimed Price”:                  5.70        substitute:             3.80
 
[108]       Schedule 1, entry for Sertraline in the form Tablet 100 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             4.73        substitute:             3.15
(b)   omit from the column headed “Claimed Price”:                  5.70        substitute:             3.80
[109]       Schedule 1, entry for Simvastatin in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             2.54        substitute:             1.52
(b)   omit from the column headed “Claimed Price”:                  5.23        substitute:             3.13
[110]       Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]
(a)   omit from the column headed “Determined Price”:             3.51        substitute:             2.11
(b)   omit from the column headed “Claimed Price”:                  6.20        substitute:             3.73
[111]       Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]
(a)   omit from the column headed “Determined Price”:             5.06        substitute:             3.04
(b)   omit from the column headed “Claimed Price”:                  7.74        substitute:             4.65
[112]       Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]
(a)   omit from the column headed “Determined Price”:             7.28        substitute:             4.37
(b)   omit from the column headed “Claimed Price”:                  9.96        substitute:             5.98
[113]       Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]
(a)   omit from the column headed “Determined Price”:             10.46     substitute:             6.28
(b)   omit from the column headed “Claimed Price”:                  13.15     substitute:             7.90
[114]       Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg
(a)   omit from the column headed “Determined Price”:             4.38        substitute:             3.85
(b)   omit from the column headed “Claimed Price”:                  7.83        substitute:             6.88
[115]       Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg
(a)   omit from the column headed “Determined Price”:             9.40        substitute:             8.27
(b)   omit from the column headed “Claimed Price”:                  12.85     substitute:             11.31
[116]       Schedule 1, entry for Sucralfate
(a)   omit from the column headed “Determined Price”:             15.35     substitute:             13.81
(b)   omit from the column headed “Claimed Price”:                  17.42     substitute:             15.67
 
[117]       Schedule 1, entry for Sumatriptan
(a)   omit from the column headed “Determined Price”:             6.09        substitute:             4.66
(b)   omit from the column headed “Claimed Price”:                  6.72        substitute:             5.14
[118]       Schedule 1, entry for Tamoxifen
(a)   omit from the column headed “Determined Price”:             14.54     substitute:             12.24
(b)   omit from the column headed “Claimed Price”:                  15.58     substitute:             13.12
[119]       Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
(a)   omit from the column headed “Determined Price”:             1.28        substitute:             1.09
(b)   omit from the column headed “Claimed Price”:                  3.24        substitute:             2.76
[120]       Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
(a)   omit from the column headed “Determined Price”:             3.48        substitute:             2.96
(b)   omit from the column headed “Claimed Price”:                  7.11        substitute:             6.05
[121]       Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
(a)   omit from the column headed “Determined Price”:             4.69        substitute:             3.98
(b)   omit from the column headed “Claimed Price”:                  9.03        substitute:             7.66
[122]       Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
(a)   omit from the column headed “Determined Price”:             5.71        substitute:             4.85
(b)   omit from the column headed “Claimed Price”:                  10.63     substitute:             9.03
[123]       Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
(a)   omit from the column headed “Determined Price”:             9.51        substitute:             7.56
(b)   omit from the column headed “Claimed Price”:                  10.31     substitute:             8.20
[124]       Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
(a)   omit from the column headed “Determined Price”:             18.82     substitute:             14.96
(b)   omit from the column headed “Claimed Price”:                  19.75     substitute:             15.70
[125]       Schedule 1, entry for Verapamil
omit:
 
Tablet containing verapamil hydrochloride 40 mg
Oral
Isoptin
100
3.92
6.74
 
Read Entire Law on www.comlaw.gov.au